NetworkNewsBreaks

ThursdayMar 10, 2022 11:07 am

NetworkNewsBreaks – Sanwire Corp.’s (SNWR) Intercept Music Hitting a High Note in Fastest-Growing Sector of the Music Industry

Sanwire’s (OTC: SNWR) wholly owned subsidiary, Intercept Music, a software-as-a-service (“SaaS”) entertainment technology company, was featured in a new interview with SmallCapVoice.com Inc. (“SCV”). Intercept Music President Tod Turner joined SCV’s Stuart Smith to discuss how the company’s marketing and distribution platform gives independent artists and labels a competitive advantage in a crowded industry. “There are about 12 million artists in the world. About 5,000 of them will get major label deals. The rest of them are all out there trying to figure out how to survive in an increasingly technical world. Our job is to give them a single…

Continue Reading

ThursdayMar 10, 2022 10:52 am

NetworkNewsBreaks – Laredo Oil Inc. (LRDC) Receives Drilling Permit for Drilling Northeast Montana Project

Laredo Oil (OTC: LRDC), an exploration and production company specializing in conventional and enhanced oil recovery techniques targeting mature and declining oil fields, was granted a drilling permit to drill an initial well in the Lustre Oil Field. The Lustre project is in the Western Williston Basin of Montana. Specifically, the permit allows the Olfert 11-4 well to be drilled with 80-acre spacing on oil interests owned by Lustre Oil Company LLC, a subsidiary of Laredo Oil. The company also announced that it is in the process of raising $20 million; that funding will be used to develop LRDC’s 10-well program.…

Continue Reading

ThursdayMar 10, 2022 10:27 am

NetworkNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Featured in Recent Power Play Interview

Eat Well Group (CSE: EWG) (OTC: EWGFF) founder, CEO and director Marc Aneed is a welcomed guest in a recent Power Play by the Market Herald interview. The Power Play segments featured interviews with company executives and focus on the latest news from the companies. During his interview with Power Play host Dave Jackson, Aneed provided listeners with a glimpse at the company’s most recent shareholder update. Talking about EWGFF’s innovation, teamwork and strong culture, Aneed touched on recent investments made by the company, including investments in Belle Pulses, Sapientia Technology and Amara(R) Organic Foods. To view the full interview,…

Continue Reading

WednesdayMar 09, 2022 2:18 pm

NetworkNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) in the Driver’s Seat Across One of the Country’s Largest, Fastest-Growing Cannabis Markets

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently announced it had received all regulatory approvals and closed its acquisition of PharmaCo, a Michigan-based marijuana company. This acquisition expands RWB’s footprint within the state, having initially only had a single product line in this market – the Platinum Vape(R) brand. Following the acquisition, RWB now controls all aspects of its Michigan operations. “This successful acquisition gives RWB access to 22 owned properties, including nine dispensaries and three cultivation sites in Glendale, Marquette and Au Gres… Going forward, RWB looks to execute its initiatives that include extending its branded product…

Continue Reading

WednesdayMar 09, 2022 2:07 pm

NetworkNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Seeking to Tap Potential of Emerging Psychedelics in Health Care Space

Delic Holdings (CSE: DELC) (OTCQB: DELCF) understands the potential of the psychedelic industry in regard to health care. While in its early stages, the industry is estimated to grow tremendously, and Delic seeks to capitalize on the sector’s potential to not only benefit millions of people dealing with mental health issues, but also create value for its shareholders. “Delic is banking on scientific research to prove the usefulness and effectiveness of psychedelics as an alternative treatment for specific mental health conditions. It also relies on customer feedback to help push the conversation and further increase the sensitization of psychedelics for…

Continue Reading

WednesdayMar 09, 2022 1:53 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Eyes Potential of First-of-Its-Kind Study

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), recently secured approval to move forward on a key feasibility study designed to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics. The Institution Review Board (“IRB”) granted the approval, which gives a green light to a Cybin-sponsored study designed around Kernel’s quantitative neuroimaging technology, Kernel Flow. The technology uses pulsed light instead of continuous wave light to increase measured brain information. The Flow device is a wearable helmet, in contrast to electroencephalography (“EEG”) electrodes that usually require the application of gel or functional magnetic resonance…

Continue Reading

WednesdayMar 09, 2022 1:40 pm

NetworkNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Embarks on 2nd Chapter of Journey, Strengthened by Relentless Team and 28K+ Early Investors

Knightscope (NASDAQ: KSCP) is a developer of advanced physical security technologies focused on enhancing U.S. security operations. A recent article discussing the company reads, “Knightscope’s shares were first announced to be listed on the Nasdaq Global Market in early December, kick-starting a public offering that raised over $22.3 million through the sale of 2,236,619 shares of the company’s Class A Common Stock as of January 26.” The piece covers Knightscope’s successful offering from which it intends to utilize the net proceeds toward the scaling of its current fleet of autonomous security robots (“ASRs”), which includes the K1, K3 and K5,…

Continue Reading

WednesdayMar 09, 2022 1:31 pm

NetworkNewsBreaks – SPYR Inc. (SPYR) Positioned for Opportunity in Smart Home Product Sector

SPYR’s (OTCQB: SPYR) wholly owned subsidiary, Applied Magix Inc., develops and resells Apple(R) ecosystem compatible products. This positions the company to take advantage of significant growth potential for Apple’s smart home device segment, represented by the variance between the number of consumers who have owned an Apple product and those who have owned a smart home device. “Acquired in October 2020, just a few months after Apple’s WWDC, Applied Magix is a registered Apple developer and reseller of Apple ecosystem compatible products targeting the burgeoning multibillion-dollar smart home market,” notes a recent article. “Applied Magix sources white-label HomeKit products and…

Continue Reading

WednesdayMar 09, 2022 1:06 pm

NetworkNewsBreaks – Hollywall Entertainment Inc. (HWAL) Drawing on Resources to Create Digital Equity

Hollywall Entertainment (OTC: HWAL), an innovative telecommunication and broadcasting company, is employing its own methods to create digital equity. The company is drawing on resources that include its vast subsidiary holdings in the realms of telecommunications, infrastructure, technology, media, entertainment, and broadcasting to benefit rural, underserved communities. Hollywall aims to address the so-called digital divide between the quality internet haves and have-nots, which disproportionately affects the elderly, individuals living in rural areas and in poverty, and people experiencing systemic homelessness, limiting their access to information and modern communication technology. “Hollywall CEO Darnell Sutton refers to the company’s vision as ‘Fiber…

Continue Reading

WednesdayMar 09, 2022 12:41 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reiterates Progress for Lead Product Candidate, Addresses Recent Share Price Activity in Video to Shareholders

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today released a video to shareholders that reiterates its operational and clinical progress for lead product candidate, Berubicin, and addresses recent share price activity. “The divergence that exists between our operational strength and share price is top of mind for myself and the whole team at CNS Pharmaceuticals. As a shareholder of CNS Pharma, I share in the frustrations as it pertains to the share price and fluctuation in the market – both…

Continue Reading